Nutlin-3a treatment activated p53-mediated apoptosis mechanisms, inducing the increased expression of proapoptotic proteins and key regulators of cell cycle arrest in ALL cell lines and primary blast cells. The gene discussed is TP53; the disease is acute lymphoblastic leukemia.